Onderzoeker
Guido Vanham
Affiliaties
- Virologie (Onderzoekseenheid)
Lid
Vanaf1 jan 1989 → 30 jul 2019
Projecten
1 - 10 of 19
- Machine learning framework voor T-cell receptor repertoiregebaseerde virale diagnostiekVanaf3 nov 2020 → Heden
- Evaluation of the role of immune checkpoint molecules in the natural killer cell-mediated anti-HIV responseVanaf11 apr 2019 → Heden
- Ontwikkeling van een nieuwe nanopartikel-formulatie voor een therapeutisch vaccin gebasseerd op mRNA tegen HIVVanaf11 apr 2019 → Heden
- Immuno Cytometry : Phenotyping immune cellular components, in the context of HBV, HIV and AD, by new, advanced technologiesVanaf18 jan 2018 → 17 aug 2020
- Interventions towards a functional cure: detailed phenotyping of the HIV-specific polyfunctional CD8+ T cell responses of controllersVanaf24 jun 2016 → 12 feb 2020
- Search for host genetic factors associated with neurological complications (HAM/TSP) in Peruvian HTLV-1 infected individualsVanaf18 mei 2016 → 27 sep 2016
- Rationeel ontwerp van een therapeutisch vaccin tegen HIV-1 gebaseerd op een nieuwe formulering van nanopartikelVanaf1 jan 2016 → 31 dec 2020
- Cell-associated HIV-RNA as a superior marker of treatment success or failureVanaf29 apr 2015 → 19 sep 2019
- Therapeutic TriMix/Mrna BASED Vaccine in Chronic HIV-1 Infected Patients Receiving Antiretroviral TherapyVanaf1 dec 2013 → 31 dec 2017
- Inductie van breed-potente Hiv-1 suppressieve immuun responsen door dendritische cellen opgeladen met gag mRNA.Vanaf1 jan 2011 → 21 mrt 2019
Publicaties
21 - 30 van 206
- Immunomodulatory therapy of visceral leishmaniasis in human immunodeficiency virus-coinfected patients(2018)
Auteurs: Wim Adriaensen, Thomas P C Dorlo, Guido Vanham, L Kestens, Paul M Kaye, J van Griensven
- Pharmacodynamic activity of DS003, a novel gp120 blocker, when administered to women as a vaginal tablet(2018)
Auteurs: Jeremy Nuttall, Kevin Ariën, J Michiels, Meryam Krit, G Vanham, Pascal van Tilburg, Leonie du Puy, Neliette van Niekerk, Annalene Nel
Pagina's: 341-341 - Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection(2018)
Auteurs: Lorna Leal, Alberto C. Guardo, Sara Moron-Lopez, Maria Salgado, Beatriz Mothe, Carlo Heirman, Pieter Pannus, G Vanham, Henk-Jan van den Ham, Rob Gruters, et al.
Pagina's: 2533-2545 - Visualization of X4-and R5-tropic HIV-1 viruses expressing fluorescent proteins in human endometrial cells: application to tropism study(2017)
Auteurs: Rachel Terrasse, Meriam Memmi, Sabine Palle, L Heyndrickx, G Vanham, Bruno Pozzetto, Thomas Bourlet
- A longitudinal analysis of the vaginal microbiota and vaginal immune mediators in women from sub-Saharan Africa(2017)
Auteurs: Vicky Jespers, J.K. Kyongo, Sarah Joseph, Liselotte Hardy, Piet Cools, Tania Crucitti, Mary Mwaura, Gilles Ndayisaba, Sinead Delany-Moretlwe, Jozefien Buyze, et al.
- Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe(2017)
Auteurs: Francois Blanquart, Chris Wymant, Marion Cornelissen, Astrid Gall, Margreet Bakker, Daniela Bezemer, Matthew Hall, Mariska Hillebregt, Swee Hoe Ong, Jan Albert, et al.
- Evolutionary dynamics and complicated genetic transmission network patterns of HIV-1 CRF01_AE among MSM in Shanghai, China(2016)
Auteurs: Xiaoshan Li, Yile Xue, Yi Lin, Jing Gai, Lei Zhang, Hua Cheng, Zhen Ning, Leiming Zhou, Kexin Zhu, G Vanham, et al.
- CD4-mimetic sulfopeptide conjugates display sub-nanomolar anti-HIV-1 activity and protect macaques against a SHIV162P3 vaginal challenge(2016)
Auteurs: Kevin Ariën, Françoise Baleux, Delphine Desjardins, Françoise Porrot, Yves-Marie Coïc, J Michiels, Kawthar Bouchemal, David Bonnaffé, Timothée Bruel, Olivier Schwartz, et al.
- Type I interferons interfere with the capacity of mRNA lipoplex vaccines to elicit cytolytic T cell responses(2016)
Auteurs: Ans De Beuckelaer, C Pollard, Sandra Van Lint, Kenny Roose, Lien Van Hoecke, Thomas Naessens, Vimal Kumar Udhayakumar, Muriel Smet, Niek Sanders, Stefan Lienenklaus, et al.
Pagina's: 2012-2020 - Resistance and cross-resistance profile of the diaryltriazine NNRTI and candidate microbicide UAMC01398(2016)
Auteurs: Kevin Ariën, Muthusamy Venkatraj, J Michiels, Jurgen Joossens, K Vereecken, Pieter Van der Veken, Jan Heeres, Hans De Winter, L Heyndrickx, Koen Augustyns, et al.
Pagina's: 1159-1168